Chief of the Division of Rheumatology
Northwell Health
Manhasset, NY, NY, United States
Professional Title:
Chief, Division of Rheumatology, Northwell Health
Professor of Medicine, Zucker School of Medicine at Hofstra/Northwell
Bio:
Dr. Richard Furie, Chief of the Division of Rheumatology at Northwell Health, is a rheumatologist whose activities for the last several decades have focused on patient care, physician education, and clinical research in the area of anti-rheumatic drug development. He directs The Program in Novel Therapeutics, the Health System’s clinical research program in musculoskeletal disease. He also directs the Hospital’s SLE and Autoimmune Disease Treatment Center, which has become internationally recognized for its role in the development of new therapies for SLE. Regarded as one of the senior rheumatologists in the New York metropolitan area, he has served as a volunteer for the local chapters of the Arthritis Foundation and the Lupus Alliance, the Lupus Foundation of America, the SLE Foundation, the Lupus Research Alliance, and Lupus Therapeutics. For twenty years he served on many committees of the American College of Rheumatology and was named a Master of the College in 2018. Although often featured as a speaker at national and international conferences, Dr. Furie’s favorite educational venue is at home with his colleagues and trainees.
Sunday, November 12, 2023
9:00 AM – 11:00 AM PT
Disclosure(s): Biogen: Consultant (Ongoing), Grant/Research Support (Ongoing)
Sunday, November 12, 2023
9:00 AM – 11:00 AM PT
Disclosure(s): Biogen: Consultant (Ongoing), Grant/Research Support (Ongoing)
Sunday, November 12, 2023
9:00 AM – 11:00 AM PT
Disclosure(s): Biogen: Consultant (Ongoing), Grant/Research Support (Ongoing)
Sunday, November 12, 2023
9:00 AM – 11:00 AM PT
Disclosure(s): Biogen: Consultant (Ongoing), Grant/Research Support (Ongoing)
Meet the Panel: The Latest in Lupus Treatment
Monday, November 13, 2023
7:30 AM – 8:15 AM PT
Disclosure(s): Biogen: Consultant (Ongoing), Grant/Research Support (Ongoing)
226: Expanding Horizons for SLE: An Innovative Therapy Option
Monday, November 13, 2023
6:00 PM – 8:00 PM PT
Disclosure(s): Biogen: Consultant (Ongoing), Grant/Research Support (Ongoing)
Tuesday, November 14, 2023
9:00 AM – 11:00 AM PT
Disclosure(s): Biogen: Consultant (Ongoing), Grant/Research Support (Ongoing)
235: Exploring New Frontiers: CAR T Cell Therapy in Autoimmune Diseases
Tuesday, November 14, 2023
6:00 PM – 8:00 PM PT
Disclosure(s): Biogen: Consultant (Ongoing), Grant/Research Support (Ongoing)
When and How to Gather: Building Social Connections and Intellectual Comradery
Wednesday, November 15, 2023
7:30 AM – 8:15 AM PT
Disclosure(s): Biogen: Consultant (Ongoing), Grant/Research Support (Ongoing)